Jubilant Pharmova Limited (JUBLPHARMA) - Total Assets

Latest as of September 2025: Rs135.21 Billion INR ≈ $1.46 Billion USD

Based on the latest financial reports, Jubilant Pharmova Limited (JUBLPHARMA) holds total assets worth Rs135.21 Billion INR (≈ $1.46 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Jubilant Pharmova Limited - Total Assets Trend (2004–2025)

This chart illustrates how Jubilant Pharmova Limited's total assets have evolved over time, based on quarterly financial data. Also see market value of Jubilant Pharmova Limited for the company's overall valuation and market capitalisation.

Jubilant Pharmova Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Jubilant Pharmova Limited's total assets of Rs135.21 Billion consist of 28.0% current assets and 72.0% non-current assets. Review how much debt does Jubilant Pharmova Limited carry to assess the company's total debt and financial obligations.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	8.5%
Accounts Receivable	Rs8.93 Billion	7.0%
Inventory	Rs11.29 Billion	8.9%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs10.97 Billion	8.6%
Goodwill	Rs25.41 Billion	19.9%

Asset Composition Trend (2004–2025)

This chart illustrates how Jubilant Pharmova Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See JUBLPHARMA stock price and chart for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Jubilant Pharmova Limited's current assets represent 28.0% of total assets in 2025, a decrease from 42.9% in 2004.
Cash Position: Cash and equivalents constituted 8.5% of total assets in 2025, up from 2.6% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, an increase from 1.0% in 2004.
Asset Diversification: The largest asset category is goodwill at 19.9% of total assets.

Jubilant Pharmova Limited Competitors by Total Assets

Key competitors of Jubilant Pharmova Limited based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Jiangsu Hengrui Medicine Co Ltd SHG:600276	China	CN¥68.33 Billion
Viatris Inc NASDAQ:VTRS	USA	$35.04 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.84 Billion
Neuland Laboratories Limited NSE:NEULANDLAB	India	Rs29.30 Billion
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	China	CN¥6.49 Billion
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	China	CN¥1.41 Billion

Jubilant Pharmova Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.66	1.80	2.10
Quick Ratio	1.07	1.20	1.32
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs13.71 Billion	Rs15.55 Billion	Rs25.50 Billion

Jubilant Pharmova Limited - Advanced Valuation Insights

This section examines the relationship between Jubilant Pharmova Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.42
Latest Market Cap to Assets Ratio	0.01
Asset Growth Rate (YoY)	10.5%
Total Assets	Rs127.56 Billion
Market Capitalization	$1.58 Billion USD

Valuation Analysis

Below Book Valuation: The market values Jubilant Pharmova Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Jubilant Pharmova Limited's assets grew by 10.5% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Jubilant Pharmova Limited (2004–2025)

The table below shows the annual total assets of Jubilant Pharmova Limited from 2004 to 2025.

Year	Total Assets	Change
2025-03-31	Rs127.56 Billion ≈ $1.38 Billion	+10.46%
2024-03-31	Rs115.48 Billion ≈ $1.25 Billion	+3.51%
2023-03-31	Rs111.57 Billion ≈ $1.21 Billion	+11.67%
2022-03-31	Rs99.91 Billion ≈ $1.08 Billion	+12.03%
2021-03-31	Rs89.18 Billion ≈ $964.46 Million	-28.78%
2020-03-31	Rs125.22 Billion ≈ $1.35 Billion	+9.18%
2019-03-31	Rs114.69 Billion ≈ $1.24 Billion	+19.24%
2018-03-31	Rs96.18 Billion ≈ $1.04 Billion	+6.38%
2017-03-31	Rs90.41 Billion ≈ $977.71 Million	+1.05%
2016-03-31	Rs89.47 Billion ≈ $967.59 Million	+3.65%
2015-03-31	Rs86.32 Billion ≈ $933.54 Million	-2.58%
2014-03-31	Rs88.61 Billion ≈ $958.24 Million	+5.08%
2013-03-31	Rs84.32 Billion ≈ $911.89 Million	+7.47%
2012-03-31	Rs78.46 Billion ≈ $848.51 Million	+3.73%
2011-03-31	Rs75.64 Billion ≈ $818.00 Million	+10.83%
2010-03-31	Rs68.25 Billion ≈ $738.05 Million	+3.35%
2009-03-31	Rs66.04 Billion ≈ $714.15 Million	+56.88%
2008-03-31	Rs42.09 Billion ≈ $455.23 Million	+29.79%
2007-03-31	Rs32.43 Billion ≈ $350.74 Million	+58.09%
2006-03-31	Rs20.51 Billion ≈ $221.86 Million	+62.46%
2005-03-31	Rs12.63 Billion ≈ $136.56 Million	+45.21%
2004-03-31	Rs8.70 Billion ≈ $94.05 Million	--

About Jubilant Pharmova Limited

NSE:JUBLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$1.58 Billion

Rs146.43 Billion INR

Market Cap Rank

#7061 Global

#347 in India

Share Price

Rs924.50

Change (1 day)

+1.83%

52-Week Range

Rs807.65 - Rs1181.20

All Time High

Rs1269.00